21 February 2002
Source: http://www.access.gpo.gov/su_docs/aces/fr-cont.html

-------------------------------------------------------------------------

[Federal Register: February 21, 2002 (Volume 67, Number 35)]
[Notices]
[Page 8011]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr21fe02-54]

-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability for Non-Exclusive, Exclusive, or Partially Exclusive
Licensing of U.S. Patent Concerning Hantavirus Vaccine

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6, announcement is made of the
availability for licensing of U.S. Patent No. 5,614,193 entitled
``Hantavirus Vaccine'' issued March 25, 1997. The United States
government as represented by the Secretary of the Amy has rights in
this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command,
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick,
Frederick, Maryland 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul
Mele, Office of Research & Technology Assessment, (301) 619-6664. Both
at telefax (301) 61-5034.

SUPPLEMENTARY INFORMATION: Vaccine formulations for inducing protective
immune response to Hantaviruses in humans are disclosed. These
formulations include an attenuated vaccine virus vector containing
cDNA's encoding Hantavirus nucleocapsid N protein, G1 and G2
glycoproteins. Methods for the use of these formulations also are
disclosed.

Luz D. Ortiz,
Army Federal Register Liaison Officer.
[FR Doc. 02-4180 Filed 2-20-02; 8:45 am]
BILLING CODE 3710-08-M
